Abstract
Purpose: Intensity modulated proton therapy (IMPT) patient specific quality assurance (QA) program based on measurement alone could be very time consuming due to highly modulated dose distributions of IMPT fields. In this work, we present our efforts for developing an efficient and effective patient specific QA program for IMPT. Methods: The improved QA program, based on a previously reported one for single field uniform dose (SFUD), consists of three components: measurements, independent dose calculation and analysis of patient specific treatment delivery log files. Measurements included two‐dimensional (2D) measurements for each field delivered at the planned gantry angles with electronic medical record (EMR) system in the QA mode and the accelerator control system (ACS) in the treatment mode and additional depths for each field with ACS in physics mode without using the EMR. Dose distributions in a water phantom for each field were calculated independently using a recently developed in‐ house pencil beam algorithm and compared with the results of TPS. The treatment log file for each field was analyzed in terms of deviations in delivered spot positions from their planned positions using various statistic analysis methods. Results: With the improved patient specific QA program, we are able to verify (1) the dose calculation of TPS, (2) integrity of the data transfer from TPS to EMR to ACS and (3) treatment delivery including dose delivered and spot positions. We estimated that the in‐room measurement time required for each complex IMPT patient like head and neck patients would be less than 2 h. Conclusions: We have developed an efficient and effective QA program for IMPT patients with the equipment and resources available in our clinic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.